Agreed, free options plus the likelihood of plenty of near term catalysts to keep the momentum running high. Ethics approval within the next few weeks, recruitment shortly after, then first dosing shortly after that. There’s of course the big one - the partnership - which could come at any moment. We know there’s a US trip planned for early Feb, perhaps they’ll also be signing a deal within the next few weeks?
- Forums
- ASX - By Stock
- PAR
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
1.69%
!
29.0¢

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-19
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.0¢ |
Change
-0.005(1.69%) |
Mkt cap ! $112.9M |
Open | High | Low | Value | Volume |
29.5¢ | 31.0¢ | 28.5¢ | $431.5K | 1.469M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 21578 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.5¢ | 9000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2785 | 0.285 |
13 | 172665 | 0.280 |
3 | 23534 | 0.275 |
4 | 24578 | 0.270 |
3 | 8195 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 20369 | 2 |
0.315 | 100233 | 3 |
0.320 | 137590 | 6 |
0.325 | 127282 | 6 |
0.335 | 45064 | 3 |
Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |